Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
OPIANT PHARMACEUTICALS, INC. (OPNT)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
27 Jan 2023
O'Toole David D
Chief Financial Officer, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
34,248
-1%
541
$20.26
$10,960.66
SELL
27 Jan 2023
Skolnick Phil
Chief Scientific Officer, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
21,548
-2%
480
$20.26
$9,724.80
SELL
27 Jan 2023
Ellison Mark Jason Heath
Chief Development Officer, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
18,751
-3%
610
$20.26
$12,358.60
SELL
27 Jan 2023
Gorman Brian
General Counsel
OPIANT PHARMACEUTICALS, INC.
(OPNT)
31,990
-1%
444
$20.26
$8,995.44
SELL
27 Jan 2023
CRYSTAL ROGER
Chief Executive Officer, Director, Officer, 10% Owner
OPIANT PHARMACEUTICALS, INC.
(OPNT)
75,339
-1%
1,358
$20.26
$27,513.08
SELL
9 Jan 2023
CRYSTAL ROGER
Chief Executive Officer, Director, Officer, 10% Owner
OPIANT PHARMACEUTICALS, INC.
(OPNT)
76,697
-1%
1,183
$20.20
$23,896.60
SELL
9 Jan 2023
Skolnick Phil
Chief Scientific Officer, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
22,028
-1%
369
$20.20
$7,453.80
SELL
9 Jan 2023
Ellison Mark Jason Heath
Chief Development Officer, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
19,361
-2%
469
$20.20
$9,473.80
SELL
9 Jan 2023
O'Toole David D
Chief Financial Officer, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
34,789
-1%
415
$20.20
$8,383.00
SELL
5 Jan 2023
CRYSTAL ROGER
Chief Executive Officer, Director, Officer, 10% Owner
OPIANT PHARMACEUTICALS, INC.
(OPNT)
77,880
-6%
5,029
$20.20
$101,585.81
SELL
5 Jan 2023
Skolnick Phil
Chief Scientific Officer, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
22,397
-5%
1,421
$20.20
$28,704.20
SELL
5 Jan 2023
Gorman Brian
General Counsel
OPIANT PHARMACEUTICALS, INC.
(OPNT)
32,434
-3%
1,313
$20.20
$26,522.60
SELL
5 Jan 2023
O'Toole David D
Chief Financial Officer, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
35,204
-4%
1,600
$20.20
$32,320.00
SELL
5 Jan 2023
Ellison Mark Jason Heath
Chief Development Officer, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
19,830
-8%
1,806
$20.20
$36,481.20
SELL
20 Jul 2022
Ruth Matthew R.
Chief Commercial Officer, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
29,916
-3%
1,084
$10.62
$11,512.08
SELL
14 Jul 2022
O'Toole David D
Chief Financial Officer, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
36,804
-2%
779
$11.10
$8,646.90
SELL
14 Jul 2022
Skolnick Phil
Chief Scientific Officer, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
23,818
-2%
627
$11.85
$7,429.95
SELL
14 Jul 2022
Gorman Brian
General Counsel
OPIANT PHARMACEUTICALS, INC.
(OPNT)
33,747
-2%
691
$11.16
$7,711.56
SELL
14 Jul 2022
CRYSTAL ROGER
Chief Executive Officer, Director, Officer, 10% Owner
OPIANT PHARMACEUTICALS, INC.
(OPNT)
82,909
-2%
2,246
$11.11
$24,953.06
SELL
13 Jun 2022
Sinclair Michael
Director, 10% Owner
OPIANT PHARMACEUTICALS, INC.
(OPNT)
19,220
-41%
13,616
$10.96
$149,187.69
BUY
10 Jun 2022
Collard Craig A
Director
OPIANT PHARMACEUTICALS, INC.
(OPNT)
53,822
+11%
5,700
$11.10
$63,266.48
SELL
9 Jun 2022
Sinclair Michael
Director, 10% Owner
OPIANT PHARMACEUTICALS, INC.
(OPNT)
32,836
-19%
7,896
$12.25
$96,726.00
SELL
6 Jun 2022
Sinclair Michael
Director, 10% Owner
OPIANT PHARMACEUTICALS, INC.
(OPNT)
40,732
-17%
8,488
$12.93
$109,770.72
SELL
2 Jun 2022
Sinclair Michael
Director, 10% Owner
OPIANT PHARMACEUTICALS, INC.
(OPNT)
49,220
-28%
20,000
$13.73
$274,623.44
SELL
2 Jun 2022
Gorman Brian
General Counsel
OPIANT PHARMACEUTICALS, INC.
(OPNT)
32,438
-3%
1,148
$13.52
$15,520.96
BUY
16 May 2022
Silver Gabrielle Alison
Director
OPIANT PHARMACEUTICALS, INC.
(OPNT)
21,343
+13%
2,500
$13.29
$33,220.00
BUY
16 May 2022
Collard Craig A
Director
OPIANT PHARMACEUTICALS, INC.
(OPNT)
48,122
+129%
27,150
$13.54
$367,611.00
BUY
13 May 2022
Collard Craig A
Director
OPIANT PHARMACEUTICALS, INC.
(OPNT)
20,972
+21%
3,689
$10.49
$38,697.61
BUY
13 May 2022
MacDougall Ann L.
Director
OPIANT PHARMACEUTICALS, INC.
(OPNT)
26,179
+12%
3,000
$10.93
$32,778.00
SELL
27 Jan 2022
Skolnick Phil
Chief Scientific Officer, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
22,445
-6%
1,518
$26.19
$39,756.42
SELL
27 Jan 2022
CRYSTAL ROGER
Chief Executive Officer, Director, Officer, 10% Owner
OPIANT PHARMACEUTICALS, INC.
(OPNT)
78,488
-2%
1,995
$26.15
$52,169.25
SELL
10 Jan 2022
O'Toole David D
Chief Financial Officer, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
35,583
-1%
432
$30.60
$13,219.20
SELL
10 Jan 2022
Skolnick Phil
Chief Scientific Officer, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
23,963
-1%
385
$30.49
$11,738.65
SELL
10 Jan 2022
CRYSTAL ROGER
Chief Executive Officer, Director, Officer, 10% Owner
OPIANT PHARMACEUTICALS, INC.
(OPNT)
80,483
-1%
1,058
$30.49
$32,258.42
SELL
21 Sep 2021
Thomas Thomas T.
Director
OPIANT PHARMACEUTICALS, INC.
(OPNT)
10,375
-13%
1,566
$24.54
$38,430.42
BUY
16 Sep 2021
CRYSTAL ROGER
Chief Executive Officer, Director, Officer, 10% Owner
OPIANT PHARMACEUTICALS, INC.
(OPNT)
5,100
+2%
100
$23.44
$2,344.00
SELL
14 Sep 2021
Thomas Thomas T.
Director
OPIANT PHARMACEUTICALS, INC.
(OPNT)
6,663
-19%
1,571
$19.37
$30,430.57
BUY
14 Sep 2021
O'Toole David D
Chief Financial Officer, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
23,994
+0%
200
$19.12
$3,824.32
BUY
14 Sep 2021
Gorman Brian
General Counsel
OPIANT PHARMACEUTICALS, INC.
(OPNT)
21,574
+6%
1,312
$19.04
$24,979.64
BUY
13 Sep 2021
Collard Craig A
Director
OPIANT PHARMACEUTICALS, INC.
(OPNT)
16,077
+18%
2,500
$18.13
$45,325.00
BUY
10 Sep 2021
Collard Craig A
Director
OPIANT PHARMACEUTICALS, INC.
(OPNT)
13,577
+239%
9,577
$18.18
$174,109.86
SELL
7 Sep 2021
Thomas Thomas T.
Director
OPIANT PHARMACEUTICALS, INC.
(OPNT)
6,653
-10%
822
$18.00
$14,796.00
BUY
31 Aug 2021
Ruth Matthew R.
Chief Commercial Officer, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
17,000
+13%
2,000
$17.34
$34,680.00
SELL
23 Aug 2021
Sinclair Michael
Director, 10% Owner
OPIANT PHARMACEUTICALS, INC.
(OPNT)
144,070
-51%
150,000
$15.71
$2,356,673.50
SELL
19 Aug 2021
Thomas Thomas T.
Director
OPIANT PHARMACEUTICALS, INC.
(OPNT)
6,400
-13%
1,000
$16.22
$16,220.00
BUY
16 Aug 2021
O'Toole David D
Chief Financial Officer, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
23,815
+2%
600
$15.38
$9,228.00
SELL
15 Mar 2021
MacDougall Ann L.
Director
OPIANT PHARMACEUTICALS, INC.
(OPNT)
20,838
-40%
14,155
$11.35
$160,669.92
SELL
15 Mar 2021
Silver Gabrielle Alison
Director
OPIANT PHARMACEUTICALS, INC.
(OPNT)
16,478
-44%
13,006
$11.31
$147,037.48
BUY
3 Sep 2020
Thomas Thomas T.
Director
OPIANT PHARMACEUTICALS, INC.
(OPNT)
5,000
+150%
3,000
$8.34
$25,025.00
BUY
11 Jun 2020
O'Toole David D
Chief Financial Officer, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
15,365
+6%
1,000
$8.74
$8,740.00
BUY
10 Jun 2020
Silver Gabrielle Alison
Director
OPIANT PHARMACEUTICALS, INC.
(OPNT)
4,515
+152%
2,730
$9.13
$24,924.90
BUY
26 May 2020
O'Toole David D
Chief Financial Officer, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
14,365
+7%
1,000
$11.00
$11,000.00
SELL
7 Jan 2020
Skolnick Phil
Chief Scientific Officer, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
7,193
-54%
8,785
$13.47
$118,347.80
SELL
2 Jan 2020
Skolnick Phil
Chief Scientific Officer, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
8,785
-12%
1,215
$13.96
$16,963.00
BUY
12 Dec 2019
MacDougall Ann L.
Director
OPIANT PHARMACEUTICALS, INC.
(OPNT)
10,000
+100%
5,000
$14.54
$72,700.00
SELL
5 Dec 2019
Skolnick Phil
Chief Scientific Officer, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
0
-100%
2,857
$13.63
$38,935.18
SELL
2 Dec 2019
Skolnick Phil
Chief Scientific Officer, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
2,857
-71%
7,143
$14.02
$100,117.59
BUY
26 Nov 2019
O'Toole David D
Chief Financial Officer, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
9,215
+1%
100
$13.22
$1,322.00
BUY
22 Nov 2019
Silver Gabrielle Alison
Director
OPIANT PHARMACEUTICALS, INC.
(OPNT)
1,785
+100%
1,785
$13.51
$24,115.35
BUY
15 Nov 2019
O'Toole David D
Chief Financial Officer, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
9,015
+13%
1,100
$14.92
$16,410.00
SELL
1 Nov 2019
Skolnick Phil
Chief Scientific Officer, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
0
-100%
10,000
$15.05
$150,528.81
SELL
1 Oct 2019
Skolnick Phil
Chief Scientific Officer, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
0
-100%
10,000
$14.68
$146,820.89
BUY
12 Sep 2019
Daly Richard J
Director
OPIANT PHARMACEUTICALS, INC.
(OPNT)
1,800
+100%
1,800
$13.90
$25,020.00
SELL
12 Sep 2019
Sinclair Michael
Director, 10% Owner
OPIANT PHARMACEUTICALS, INC.
(OPNT)
69,220
-46%
60,000
$12.52
$751,200.00
SELL
3 Sep 2019
Skolnick Phil
Chief Scientific Officer, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
0
-100%
10,000
$14.15
$141,523.25
BUY
15 Aug 2019
O'Toole David D
Chief Financial Officer, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
8,015
+14%
1,000
$15.20
$15,200.00
BUY
13 Aug 2019
O'Toole David D
Chief Financial Officer, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
7,015
+16%
1,000
$15.46
$15,460.00
SELL
1 Aug 2019
Skolnick Phil
Chief Scientific Officer, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
0
-100%
10,000
$11.60
$116,039.12
SELL
1 Jul 2019
Skolnick Phil
Chief Scientific Officer, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
0
-100%
10,000
$13.19
$131,912.20
SELL
3 Jun 2019
Skolnick Phil
Chief Scientific Officer, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
0
-100%
10,000
$11.71
$117,057.27
SELL
1 May 2019
Skolnick Phil
Chief Scientific Officer, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
0
-100%
10,000
$11.39
$113,855.03
SELL
5 Apr 2019
CRYSTAL ROGER
Chief Executive Officer, Director, Officer, 10% Owner
OPIANT PHARMACEUTICALS, INC.
(OPNT)
8,475
-77%
28,773
$12.03
$346,233.20
SELL
2 Apr 2019
CRYSTAL ROGER
Chief Executive Officer, Director, Officer, 10% Owner
OPIANT PHARMACEUTICALS, INC.
(OPNT)
15,776
-57%
21,227
$12.00
$254,743.33
SELL
1 Apr 2019
Skolnick Phil
Chief Scientific Officer, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
0
-100%
10,000
$12.66
$126,618.32
SELL
1 Mar 2019
Skolnick Phil
Chief Scientific Officer, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
2,701
-78%
10,000
$14.95
$149,535.05
SELL
1 Feb 2019
Skolnick Phil
Chief Scientific Officer, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
0
-100%
10,000
$15.32
$153,174.40
SELL
4 Jan 2019
CRYSTAL ROGER
Chief Executive Officer, Director, Officer, 10% Owner
OPIANT PHARMACEUTICALS, INC.
(OPNT)
8,475
-85%
50,000
$13.34
$666,962.75
SELL
2 Jan 2019
Skolnick Phil
Chief Scientific Officer, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
0
-100%
10,000
$13.76
$137,596.48
SELL
3 Dec 2018
Skolnick Phil
Chief Scientific Officer, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
0
-100%
4,321
$16.06
$69,392.35
SELL
6 Nov 2018
Skolnick Phil
Chief Scientific Officer, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
0
-100%
3,217
$16.81
$54,077.77
SELL
1 Nov 2018
Skolnick Phil
Chief Scientific Officer, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
3,217
-36%
1,821
$18.01
$32,789.94
SELL
5 Oct 2018
CRYSTAL ROGER
Chief Executive Officer, Director, Officer, 10% Owner
OPIANT PHARMACEUTICALS, INC.
(OPNT)
8,475
-56%
10,847
$17.21
$186,651.69
SELL
2 Oct 2018
Skolnick Phil
Chief Scientific Officer, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
0
-100%
4,778
$18.32
$87,545.77
SELL
2 Oct 2018
CRYSTAL ROGER
Chief Executive Officer, Director, Officer, 10% Owner
OPIANT PHARMACEUTICALS, INC.
(OPNT)
19,322
-48%
18,450
$18.11
$334,141.00
BUY
14 Aug 2018
O'Toole David D
Chief Financial Officer, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
5,015
+25%
1,015
$15.40
$15,636.00
BUY
4 Jun 2018
MacDougall Ann L.
Director
OPIANT PHARMACEUTICALS, INC.
(OPNT)
106
+102%
5,000
$16.51
$82,566.71
SELL
16 May 2018
Thomas Thomas T.
Director
OPIANT PHARMACEUTICALS, INC.
(OPNT)
0
-100%
2,763
$16.44
$45,412.71
BUY
16 May 2018
O'Toole David D
Chief Financial Officer, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
5,000
+66%
2,000
$16.95
$33,900.00
SELL
11 May 2018
Thomas Thomas T.
Director
OPIANT PHARMACEUTICALS, INC.
(OPNT)
2,763
-60%
4,300
$18.35
$78,914.01
BUY
11 May 2018
O'Toole David D
Chief Financial Officer, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
3,000
+100%
3,000
$18.85
$56,550.00
SELL
14 Dec 2017
WOLF GEOFFREY
10% Owner
OPIANT PHARMACEUTICALS, INC.
(OPNT)
98,000
-63%
173,716
$22.52
$3,911,834.00
SELL
13 Dec 2017
WOLF GEOFFREY
10% Owner
OPIANT PHARMACEUTICALS, INC.
(OPNT)
73,637
-32%
34,938
$22.67
$792,207.56
SELL
1 Dec 2017
WOLF GEOFFREY
10% Owner
OPIANT PHARMACEUTICALS, INC.
(OPNT)
107,804
-2%
2,570
$30.40
$78,128.00
BUY
17 Jan 2017
CRYSTAL ROGER
Chief Executive Officer, Director, Officer, 10% Owner
OPIANT PHARMACEUTICALS, INC.
(OPNT)
8,475
+69%
3,475
$6.99
$24,290.25
BUY
17 Jan 2017
Sinclair Michael
Executive Chairman, Director, Officer, 10% Owner
OPIANT PHARMACEUTICALS, INC.
(OPNT)
132,720
+2%
3,500
$7.01
$24,517.50
BUY
13 Jan 2017
Pollack Kevin
See Remarks, Director, Officer
OPIANT PHARMACEUTICALS, INC.
(OPNT)
4,820
+100%
4,820
$6.98
$33,643.60
Home